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Extensive chromatographic purification of the alkaloid fraction of Aconitum vulparia Rchb. led to
the isolation of a new norditerpene alkaloid, vulparine (1), besides the known compounds septentri-
odine (2), finetiadine (3), anthranoyllycoctonine (4), N-methyl-N-deethyllycoctonine (5) and delecti-
nine (6). The structure of the new compound was determined by means of HRMS, 1D and 2D NMR
spectroscopy. Detailed NMR studies, including 1H-1H COSY, NOESY, HSQC and HMBC experi-
ments, resulted in complete and unambiguous 1H chemical shift assignments for 2 and 6, and revi-
sion of some 13C NMR data. Compounds 1 – 4 were evaluated for their cytotoxic activities, and 1, 3
and 4 were found to exhibit marginal cell growth inhibitory activity against breast adenocarcinoma
(MCF-7) and cervix adenocarcinoma (HeLa) cells.
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Introduction
Aconitum, Delphinium and Consolida species are
known to produce various hydroxy-, alkoxy- and ester-
substituted diterpene and norditerpene alkaloids. Many
C19 lycoctonine-type alkaloids exhibit high toxic-
ity and a broad spectrum of pharmacological activi-
ties, including antinociceptive, anti-inflammatory, lo-
cal anaesthetic, antioxidant and tyrosinase inhibitory
activities [1 – 3]. Moreover, norditerpene alkaloids
with an N-substituted anthranylate ester side-chain,
e. g. methyllycaconitine (MLA), display extremely
great affinity and high selectivity for the α7 nico-
tinic acetylcholine receptor (nAChR) subtype, and are
therefore prime lead compounds for the design and
synthesis of new drugs for the therapy of Alzheimer’s
disease, epilepsy and schizophrenia [4, 5]. In recent
years it was demonstrated that norditerpene alkaloids
can act on biological targets other than neuroreceptors:
they exhibit cytotoxic effect against insect Sf9 and dif-
ferent human tumour cell lines with strong molecular
selectivity [6 – 8]. In a previous paper, we reported the
isolation of a new norditerpene alkaloid, acovulparine,
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from A. vulparia, together with lycoctonine and del-
cosine [9]. On completion of our studies on this plant,
we now describe the isolation and structure elucidation
of a further new norditerpene alkaloid, vulparine (1),
and five known compounds: septentriodine (2), fine-
tiadine (3), anthranoyllycoctonine (4), N-methyl-N-de-
ethyllycoctonine (5) and delectinine (6). The complete
and unambiguous 1H and 13C NMR signal assignments
of compounds 2 and 6, and the results of the cyto-
toxic assay of vulparine (1), septentriodine (2), finetia-
dine (3), anthranoyllycoctonine (4) on breast adenocar-
cinoma (MCF-7) and cervix adenocarcinoma (HeLa)
cells are also reported in this paper.
Results and Discussion
Compound 1 was isolated as an amorphous solid.
The molecular formula C36H50N2O11 was derived
from the HR mass spectrum ([M+H]+ m/z = 687.3437,
[M+H]+ calcd. 687.3493) combined with the NMR
data. The 1H NMR spectrum of 1 indicated the pres-
ence of aromatic protons (δH = 7.11 t, 7.55 t, 7.96 d,
8.70 d), which were attributed to an anthranoyl group,
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Scheme 1.
found in many Aconitum alkaloids. Additionally, sig-
nals of the protons of four methoxy groups (δ H =
3.26 s, 3.36 s, 3.39 s, 3.70 s) and one N-ethyl sub-
stituent (δH = 1.07 t, 2.85 dq, 2.97 dq) were present.
In the JMOD spectrum (J-modulated spin-echo exper-
iment), the signals of 36 carbons could be identified
(Table 1). Apart from the signals of the anthranoyl
group (δC = 114.7, 120.7, 122.6, 130.3, 134.9, 141.7,
168.1), four methoxy groups (δ C = 51.8, 55.9, 56.6,
58.4) and an N-ethyl substituent (δC = 14.1, 51.1), 19
signals could be identified, assignable to a norditer-
pene core. The remaining 4 signals (δC = 29.0, 32.8,
170.2, 172.0) revealed the presence of a succinoyl
chain (–COCH2CH2CO–) in the molecule. The HSQC
experiments allowed the assignment of protons and
protonated carbons. Interpretation of the proton-proton
connectivities in the 1H-1H COSY spectrum led to
the identification of three structural fragments [–CH–
CH2–CH2– (fragment A), –CH–CH– (fragment B) and
–CH–CH–CH(OR)–CH(CH(OR)–CH2)–CH2– (frag-
ment C)], two isolated methylenes (δH = 2.53 d, 2.78 m
and 4.15 d, 4.20 d, respectively), one isolated methine
(δH = 3.28 s), and one ethyl group (Fig. 1).
The long-range HMBC correlations confirmed,
that structural fragments A-C, two methylene groups
(C-18, C-19) and one methine group (C-17) together
with the quaternary carbons C-4, C-7, C-8, C-11 build
up the norditerpene skeleton. Important two- and three-
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Fig. 1. Selected 1H-1H COSY ( ) and HMBC (C → H)
correlations for 1.
bond correlations were observed between the quater-
nary carbon at δC = 48.4 (C-11) and the protons at δH =
3.02 (H-1), 1.80 (H-5), 3.89 (H-6) and 3.28 (C-17), and
between the carbon at δC = 37.9 (C-4) and the pro-
tons at δH = 1.80 (H-5), 3.89 (H-6), 4.20 (H-18a), 4.15
(H-18b) and 2.78 (H-19a), indicating that fragment A
and the quaternary carbons C-4 and C-11 form a six-
membered ring. The correlations of the carbon at δ C =
89.3 (C-7) with the protons at δH = 3.89 (H-6) and
2.50 (H-15β ), of the carbon at δC = 76.3 (C-8) with
the protons at δH = 3.89 (H-6), 3.13 (H-9) and 2.50
(H-15β ) and of the carbon at δC = 46.1 (C-10) with
the protons at δH = 3.02 (H-1) and 1.80 (H-5) proved
the linkage of structural parts C and B with the six-
membered ring, as depicted in Fig. 1. The HMBC spec-
trum also provided information on the locations of the
four methoxy groups, one anthranoyl group, and one
hydroxy group. The long-range correlations of the car-
bons of the norditerpene core at δC = 76.3 (C-8), 81.8
(C-16), 84.8 (C-1) and 90.6 (C-6) with the protons at
δH = 3.53 (1H), 3.36, 3.26 and 3.39 (each 3H) revealed
the positions of one hydroxy group at C-8 and three
methoxy groups at C-16, C-1 and C-6. The correlation
of the carbon at δC = 52.6 (C-19) with the proton at
δH = 2.97 (H-20a) confirmed the position of the N-
ethyl group. The position of the anthranoyl group at
C-18 was determined via the correlations of the car-
bonyl carbon at δC = 168.1 (C-7′) with the protons at
δH = 8.70 (H-3′), 7.96 (H-6’), 4.20 (H-18a) and 4.15
(H-18b). In view of the molecular formula of 1 and the
13C chemical shifts of C-7 (δC = 89.3) and C-14 (δC =
75.3), the presence of further two hydroxy groups was
concluded, situated at C-7 and C-14. Moreover, the
presence of a –CO–CH2–CH2–COOCH3 side-chain,
attached to the amino group of the anthranoyl moi-
ety, was demonstrated by several correlations of car-
bonyl carbons [δC = 170.2 (C-1′′) and 172.0 (C-4′′)]
with methylene protons [δH = 2.76 (4H, H-2′′, H-3′′)],
a methoxy group (δH = 3.70) and the NH group (δH =
11.07) (Table 1).
The relative stereochemistry of 1 was studied by
means of a NOESY experiment and evaluation of the
coupling constants. As starting point, the stereochem-
istry of H-5 was considered to be β , as characteris-
tic for norditerpene alkaloids [10]. The coupling con-
stant (J = 0 Hz) between H-5 and H-6 demonstrated
the α position of H-6 [9]. The Overhauser effect be-
tween H-5 and H-18 was indicative of the β position
of H-18. Consequently, H-19 must be in the α posi-
tion, and the N-containing bridge between C-19 and
C-17 is below the plane of the six-membered ring. The
NOESY correlation between H-17 and H-16 pointed
to an α-oriented H-16. The stereochemistry of C-1
was determined from the NOESY cross-peaks between
H-19 and H-2α and between H-2β and H-1. The β ori-
entation of H-1 was corroborated by comparison of its
coupling constant (J = 10.3, 7.1 Hz) with those pub-
lished for this type of norditerpene alkaloids [11, 12].
Further important NOEs were detected between H-9
and H-14, between H-9 and 8-OH, and between H-13
and H-14, which confirmed the same stereostructure
of compound 1 as that of the co-occurring lycoctonine,
with β -oriented H-9, H-13, H-14 and 8-OH [9]. Addi-
tionally, some NOESY correlations were suitable for
the steric differentiation of methylene protons (C-2,
C-3 and C-15). Such correlations were observed be-
tween H-19a and H-2α; H-2β and H-3β ; H-16 and
H-15α; and H-17 and H-15α . All of the above ev-
idence confirmed the structure 1 for this compound,
named vulparine.
Compound 2 was identified as septentriodine
(= cashmiradelphine) by comparison of its physical
and spectral data with those reported in the litera-
ture [13, 14]. This compound was previously isolated
from Aconitum septentrionale [13] and from A. bar-
batum var. puberulum [15] under the name septentri-
odine, and from Delphinium cashmirianum under the
name cashmiradelphine. In these earlier publications,
the structure was presented with a β -oriented 1-OMe
group. In a later publication by the Pelletier group,
this substituent was placed in the α position [16]. Our
NOESY experiment provided unequivocal evidence
for a 1α-OMe group, since Overhauser effects were
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Atom 1H 13C HMBC (C→H) COSY (H No.)
1 3.02 dd (7.1, 10.3) 84.8 1-OMe 2α , 2β
2α 2.15 m 25.4 – 1, 2β , 3α , 3β
2β 2.05 m 1, 2α , 3β
3α 1.82 m 32.3 18a, 18b, 19b 2α , 3β
3β 1.50 m 2α , 2β , 3α
4 – 37.9 5, 6, 18a, 18b, 19a –
5 1.80 s 50.7 17, 18a, 19a 6, 17*
6 3.89 s 90.6 5, 17, 6-OMe 5
7 – 89.3 6, 15α –
8 – 76.3 6, 8-OH, 9, 15β –
9 3.13 brs 45.2 – 10, 14
10 1.84 m 46.1 1, 5, 9, 12 9
11 – 48.4 1, 5, 6, 17 –
12 1.87 m (2H) 27.6 9 13
13 2.43 m 36.5 – 12, 14
14 4.00 brs 75.3 – 9, 13, 14-OH
15α 2.50 m 33.2 8-OH 15β
15β 1.82 m 15α
16 3.48 m 81.8 15β , 16-OMe 13, 15α
17 3.28 s 65.0 1, 5, 19a 5*
18a 4.20 d (11.0) 69.8 5, 19b
18b 4.15 d (11.0)
19a 2.78 m 52.6 5, 17, 18a, 18b, 20a 19b
19b 2.53 d (8.9) 19a
20a 2.97 dq (14.0, 7.1) 51.1 21 20b, 21
20b 2.85 dq (14.0, 7.1) 20a, 21
21 1.07 t (7.1) 14.1 20a 20a, 20b
1′ – 114.7 3′, 5′, NH –
2′ – 141.7 4′, 6′ –
3′ 8.70 ′d′ (8.3) 120.7 5′ 4′
4′ 7.55 ′t′ (7.6) 134.9 6′ 3′, 5′, 6′
5′ 7.11 ′t′ (8.0) 122.6 3′ 4′, 6′
6′ 7.96 ′d′ (8.0) 130.3 4′ 4′, 5′
7′ – 168.1 3′, 6′, 18a, 18b –
1′′ – 170.2 2′′, 3′′, NH –
2′′ 2.76 m (2H) 29.0 3′′ –
3′′ 2.76 m (2H) 32.8 2′′ –
4′′ – 172.0 2′′, 3′′, 4′′-OMe –
1-OMe 3.26 s 55.9 1 –
6-OMe 3.39 s 58.4 6 –
16-OMe 3.36 s 56.6 – –
4′′-OMe 3.70 s 51.8 – –
8-OH 3.53 s – –
14-OH 4.33 brs – 14
NH 11.07 brs – –
Table 1. NMR spectral data of
vulparine (1) [500 MHz (1H),
125 MHz (13C), CDCl3, δ
(ppm) (J = Hz)].
* 4JH,H correlations.
detected between H-1 and H-5, and between H-1 and
H-10. A detailed NMR study, including 1H-1H COSY,
HSQC and HMBC measurements, allowed (previously
unpublished) 1H chemical shift assignments for all the
protons of 2 (Table 2). On the basis of the HMBC
experiment, the 13C NMR chemical shifts of 2 were
reinvestigated, and some signal assignments were cor-
rected. The long-range correlations of the carbon at
δC = 50.4 (C-5) with H-18, and of the carbon at
δC = 43.1 (C-9) with H-13, H-14 and H-15a, dictated
amendment of the previous assignments of C-5 and
C-9. Similarly, the HMBC cross-peaks of the carbon at
δC = 45.9 (C-10) with H-9 and H-13, and of the carbon
at δC = 37.9 (C-13) with H-9, H-14 and H-15a, showed
that the published assignments of C-10 and C-13 must
be reversed.
Compound 3 was found to be identical in all of its
characteristics, including the 1H and 13C NMR spec-
tral data, with finetiadine isolated earlier from A. fine-
tianum [17]. Alkaloids 1 – 3 are structurally closely re-
lated to the highly potent nAChR ligand MLA, and
appear worthy of pharmacological studies. Norditer-
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Table 2. 1H NMR spectral data of compounds 2 and 6
[500 MHz, CDCl3, δ (ppm), (J = Hz)].
H 2 6
1 3.03 m 2.96 m
2a 2.18 m (α) 2.12 m
2b 2.06 m (β ) 2.03 m
3a 1.85 m (α) 1.66 m
3b 1.55 m (β ) 1.47 m
5 1.74 s 1.77 s
6 3.91 s 3.83 brs
9 3.08 dd (6.8, 5.0) 3.13 m
10 1.97 m 1.82 m
12a 2.41 d (11.3) (α) 1.83 m (2H)
12b 1.85 m (β )
13 2.34 dd (7.1, 4.6) 2.42 m
14 3.61 t (4.6) 3.99 brs
15a 2.61 dd (15.3, 8.9) (α) 2.49 dd (15.3, 7.8)
15b 1.69 dd (15.3, 7.0) (β ) 1.81 m
16 3.22 t (7.6) 3.46 m
17 2.98 s 3.23 s
18a 4.20 d (11.6) 3.62 d (10.3)
18b 4.17 d (11.6) 3.35 d (10.3)
19a 2.87 d (11.7) 2.61 d
19b 2.80 m 2.32 d
20a 3.03 m 2.94 m
20b 2.87 m 2.82 m
21 1.07 t (7.1) 1.05 t (7.0)
3′ 8.69 d (8.5) –
4′ 7.55 dt (8.0, 1.5) –
5′ 7.10 dt (7.6, 0.7) –
6′ 7.96 dd (8.0, 1.5) –
2′′, 3′′ 2.75m (4H) –
1-OMe 3.26 s 3.26 s
6-OMe 3.37 s 3.44 s
14-OMe 3.40 s –
16-OMe 3.34 s 3.36 s
4′′-OMe 3.70 s –
8-OH 3.91 brs 3.61 s
14-OH – 4.31 brs
NH 11.06 brs –
pene alkaloids substituted with 2-succinimidobenzoate
groups (e. g. MLA) often occur in Aconitum and Del-
phinium species, but compounds in which the succin-
imido part is opened (such as 1 – 3) are rare [10].
The 13C chemical shifts and physical data for 4 con-
firmed that this compound is identical with anthranoyl-
lycoctonine (= inuline), previously detected in many
species of the genera Aconitum, Delphinium, Consol-
ida and Inula [10].
The NMR spectral data on compound 5 were very
similar to those of lycoctonine. The only difference
was the absence of the signals of the N-ethyl group
(δH = 2.93 m, 2.79 dq, 1.04 t; δC = 51.1, 14.1 in ly-
coctonine) [9] and the appearance of an N-methyl sig-
nal (δH = 2,62 s; δC = 44.4). The good agreement
of the other 1H and 13C NMR data for 5 and lycoc-
Table 3. Cytotoxic activity of compounds 1 – 4.
Compound Concentration Inhibition (%)±SEM
(µg/mL) MCF-7 HeLa
Vulparine (1) 10 < 15 < 15
30 < 15 < 15
Septentriodine (2) 10 < 15 < 15
30 34.50±3.72 < 15
Finetiadine (3) 10 19.28±4.24 19.91±1.76
30 39.48±3.42 25.59±1.87
Anthranoyl 10 29.82±5.69 < 15
-lycoctonine (4) 30 20.70±3.02 17.33±1.60
Cisplatin 3 53.01±2.33 42.55±2.92
30 86.90±1.24 99.93±0.26
tonine proved the structure N-methyl-N-deethyllycoc-
tonine for compound 5. Previously, only the mass spec-
trum of N-methyl-N-deethyllycoctonine had been re-
ported [18].
Compound 6 was a trimethoxy-tetrahydroxy-
substituted lycoctonine-type alkaloid, which, with the
aid of 2D NMR measurements, was identified as
delectinine. The previously reported spectral data [10]
on delectinine (6) were supplemented with complete
1H NMR assignments (Table 2), and with the correc-
tion of some of the 13C NMR chemical shifts. Di-
agnostic long-range correlations between C-5/H-17,
C-9/H-10 and C-9/H-14, and 1H-1H COSY correla-
tions between H-10/H-9, H-13/H-12, H-13/H-14 and
H-13/H-16, were indicative of the need to correct the
13C NMR chemical shifts of C-5 and C-9, and C-10
and C-13.
The isolated norditerpene alkaloids 1 – 4 were tested
for their cytotoxic effect on MCF-7 and HeLa cells us-
ing MTT assay. The cell growth-inhibitory potencies of
compounds 1 – 4 are shown in Table 3. Finetiadine (3)
exhibited the highest cytotoxicity (39.48±3.42% and
25.59± 1.87 % inhibition on MCF-7 and HeLa cells,
respectively, at 30 µg/mL). Septentriodine (2) and
anthranoyllycoctonine (4) displayed marginal tumour
cell inhibitory activity, while vulparine (1) was found
to be inactive. In all cases MCF-7 cells were more
sensitive than HeLa cells. The present results demon-
strate that some anthranoyl-substituted norditerpene
alkaloids possess weak cytotoxic potencies against hu-




Optical rotations were determined in CHCl3 with a
Perkin-Elmer 341 polarimeter. UV spectra were recorded on
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a Shimadzu UV-2101 PC spectrometer. NMR spectra were
recorded in CDCl3 on a Bruker Avance DRX 500 spectrome-
ter, at 500 MHz (1H) and 125 MHz (13C), with TMS as inter-
nal standard. 2D data were acquired and processed with stan-
dard Bruker software. HRMS measurement was performed
on a VG ZAB SEQ hybrid mass spectrometer equipped with
a Cs SIMS ion source. The resolution was 10000. The sam-
ple was dissolved in methanol and this solution was mea-
sured with glycerol as matrix. The glycerol cluster peak at
m/z = 645 was used in peak matching experiments. Centrifu-
gal TLC was performed with a Chromatotron (Model 8924,
Harrison Research).
Plant material
Aconitum vulparia Rchb. was collected in the region of
Nagyvázsony, Hungary, in September 2002, and was iden-
tified by András Mészáros, Balaton Uplands National Park,
Veszprém, Hungary. A voucher specimen (No. 617) has been
deposited in the Herbarium of the Department of Pharmacog-
nosy, University of Szeged, Szeged, Hungary.
Extraction and isolation
Dried whole plants of A. vulparia (250 g) were crushed
in a blender and then percolated with MeOH (12 L). Af-
ter evaporation, the crude extract was dissolved in 4 % aq.
H2SO4 (250 mL) and extracted exhaustively with CHCl3,
which yielded organic layer I and aqueous layer II. Af-
ter adjustment of the pH to 12, aqueous layer II was ex-
tracted with CHCl3, affording organic layer III. This frac-
tion (III) was evaporated under reduced pressure, and frac-
tionated by VLC (VLC I) on Al2O3, using a gradient
system of n-hexane/EtOAc/MeOH (50 : 50 : 1, 50 : 50 : 1.5,
50 : 50 : 2, 50 : 50 : 3, 50 : 50 : 4, 50 : 50 : 5, 50 : 50 : 10). Frac-
tions obtained with n-hexane/EtOAc/MeOH 50 : 50 : 3,
50 : 50 : 4 and 50 : 50 : 5 were further fractionated by VLC
on Al2O3, using a gradient system of n-hexane/CHCl3
(7 : 3, 6 : 4, 1 : 1, 4 : 6, 3 : 7, 2 : 8, 1 : 9). Compound 2
was obtained in pure form from the fractions eluted
with n-hexane/CHCl3 6 : 4. The fractions eluted with n-
hexane/CHCl3 1 : 1 were further purified by gel chromatog-
raphy, using MeOH/CHCl3 1 : 1 as solvent, yielding com-
pound 1. Organic layer I was extracted with 2 % aque-
ous H2SO4, which afforded aqueous layer IV. Aqueous
layer IV was then rendered alkaline with 5 % aqueous
NaOH solution, and extracted with CHCl3 (organic layer V).
Phase V was evaporated in vacuo, and separated by VLC
(VLC II), using a gradient system of n-hexane/EtOAc/MeOH
(Al2O3; 50 : 50 : 0.5, 50 : 50 : 1, 50 : 50 : 1.5, 50 : 50 : 2,
50 : 50 : 3, 50 : 50 : 4, 50 : 50 : 5, 50 : 50 : 10, 1 : 1:1). The
fractions obtained by eluting with n-hexane/EtOAc/MeOH
50 : 50 : 0.5 were further purified by gel chromatography
(solvent: MeOH/CHCl3 1 : 1) and preparative TLC (SiO2,
petroleum ether/diethyl ether/MeOH 50 : 50 : 7), affording
compound 4. The fractions eluted from VLC II with n-
hexane/EtOAc/MeOH 50 : 50 : 2 and 50 : 50 : 3 were further
purified by centrifugal TLC (SiO2, gradient elution with cy-
clohexane/EtOAc/EtOH 1 : 0:0, 9 : 1:0, 8 : 2 : 1, 6 : 3:1, 0 : 1:1,
0 : 0:1). The fractions derived from centrifugal TLC with
n-hexane/EtOAc/MeOH 8 : 2:1 were subjected to prepara-
tive TLC (SiO2, toluene/acetone/EtOH/NH3 70 : 40 : 12 : 3),
yielding compound 3. The fractions eluted from VLC II
with n-hexane/EtOAc/MeOH 50 : 50 : 3 and 50 : 50 : 4 were
further fractionated by column chromatography on SiO2
with mixtures of cyclohexane/CHCl3/MeOH. The diter-
pene alkaloid-containing fractions from this chromatogra-
phy were subjected to RP-VLC (RP-SiO2, MeOH/H2O
1 : 1, 55 : 45, 60 : 40, 65 : 35, 70 : 30, 80 : 20, 90 : 10). The fi-
nal purification was performed by preparative TLC (SiO2,
toluene/acetone/EtOH/NH3 70 : 50 : 35 : 6), affording com-
pound 5. The fractions eluted from VLC II with n-
hexane/EtOAc/MeOH 50 : 50 : 10 were subjected to prepar-
ative TLC (SiO2, toluene/acetone/EtOH/NH3 70 : 50 : 35 : 6)
and gel chromatography (CHCl3/MeOH 1 : 1), yielding com-
pound 6.
Vulparine (1): amorphous solid; [α]27D = +47 (c = 0.1,
CHCl3). – UV (MeOH): λmax (logε) = 223 (3.04), 227 sh
(3.01), 252 (2.75), 260 sh (2.65), 311 (2.32) nm. – 1H and
13C NMR data, see Table 1. – HRMS: m/z (%) = 687.3437
[M+H]+ (calcd. 687.3493 for C36H51N2O11).
Septentriodine (2): amorphous solid; [α]27D = +37
(c = 0.05, CHCl3). – UV (MeOH): λmax (logε) = 222
(2.99), 227 sh (2.97), 252 (2.71), 260 sh (2.61), 310
(2.28) nm. – 1H NMR data, see Table 2. – 13C NMR
(CDCl3): δ = 83.8, 83.6 (C-1, C-14), 25.8 (C-2), 32.2
(C-3), 37.4 (C-4), 50.4 (C-5), 90.8 (C-6), 88.3 (C-7),
77.5 (C-8), 43.1 (C-9), 45.9 (C-10), 48.9 (C-11), 28.5
(C-12), 37.9 (C-13), 33.6 (C-15), 82.4 (C-16), 64.2
(C-17), 69.7 (C-18), 52.4 (C-19), 50.7 (C-20), 13.8 (C-21),
114.5 (C-1′), 141.5 (C-2′), 120.5 (C-3′), 134.6 (C-4′),
122.4 (C-5′), 130.1 (C-6′), 167.8 (C-7′), 170.0 (C-1′′),
28.8 (C-2′′), 32.5 C-3′′), 172.7 (C-4′′), 55.5 (1-OMe),
57.9 (6-OMe), 57.6 (14-OMe), 56.0 (16-OMe), 51.6
(4′′-OMe).
Finetiadine (3): amorphous solid; [α]27D = +27 (c = 0.05,
CHCl3). – UV (MeOH): λmax (logε) = 222 (3.06), 228 sh
(3.02), 253 (2.77), 260 sh (2.68), 311 (2.36) nm. – 1H
and 13C NMR data identical with those reported by Wu et
al. [17].
Anthranoyllycoctonine (4): amorphous solid; [α]27D = +80
(c = 0.025, CHCl3). – UV (MeOH): λmax (logε) = 220
(3.08), 248 (2.57), 340 (2.39) nm. – 1H and 13C NMR data
identical with those published by Hardick et al. [5].
N-Deethyl-N-methyllycoctonine (5): amorphous solid;
1H NMR (CDCl3): δ = 2.93 (1H, dd, J = 10.0, 7.3 Hz, H-1),
3.85 (1H, s, H-6), 3.07 (1H, t, J = 5.7 Hz, H-9), 2.81 (1H,
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d, J = 1.6, H-17), 2.62 (1H, d, J = 9.1 Hz, H-18a), 3.45,
3.42, 3.34, 3.27 (4× 3H, 4× s, 4×OCH3), 2.62 (3H, s, N-
CH3). – 13C NMR (CDCl3): δ = 84.7 (C-1), 26.1 (C-2), 29.7
(C-3), 49.5 (C-5), 90.5 (C-6), 77.9 (C-8), 43.3 (C-9), 46.2
(C-10), 28.8 (C-12), 38.1 (C-13), 84.0 (C-14), 33.7 (C-15),
82.6 (C-16), 66.1 (C-17), 55.5 (C-18), 67.9 (C-19), 56.2,
58.0, 57.8, 56.3 (4×OCH3), 44.4 (N-CH3). – 13C NMR sig-
nals of C-4, C-7 and C-11 were not observed.
Delectinine (6): amorphous solid; [α]27D = +31 (c = 0.05,
CHCl3). – UV (MeOH): λmax (logε) = 203 (2.95), 218 sh
(2.78), 280 (2.06) nm. – 1H NMR data, see Table 2. –
13C NMR (CDCl3): δ = 85.2 (C-1), 25.4 (C-2), 31.7 (C-3),
38.9 (C-4), 49.6 (C-5), 90.2 (C-6), 89.1 (C-7), 76.3 (C-8),
45.1 (C-9), 46.1 (C-10), 48.2 (C-11), 27.5 (C-12), 36.4
(C-13), 75.3 (C-14), 33.1 (C-15), 81.8 (C-16), 65.4 (C-17),
67.8 (C-18), 52.7 (C-19), 51.2 (C-20), 14.3 (C-21), 56.0
(1-OMe), 58.1 (6-OMe), 56.5 (16-OMe).
Bioassay
Cytotoxic effects were measured in vitro on HeLa (cervix
adenocarcinoma) and on breast adenocarcinoma (MCF-7)
cell lines, using the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] colorimetric assay. The cyto-
toxicity tests were carried out in 96-well microtitre plates,
using 5000 cells per well in all cases, which were allowed
to adhere overnight before the drugs were introduced. The
original medium was then removed, 200 µL culture medium
containing the compounds of interest was added and the cells
were incubated for 72 h. The tested compounds were dis-
solved in DMSO. The final concentration of DMSO never ex-
ceeded 0.3 %, and therefore had no essential effect on the cell
growth. Next the living cells were assayed: aliquots (20 µL
at 5 mg/mL) of the MTT stock solution were pipetted into
each well and reduced by viable cells to an insoluble for-
mazan product during a further 4 h. After this contact period,
the medium was removed and the formazan crystals were
dissolved in 100 µL DMSO by gentle shaking for 60 min.
Finally, the absorbance was measured at 545 nm with a mi-
croplate reader [19]. In this way the cell growth or drug tox-
icity was determined. All in vitro experiments were carried
out on two microplates with at least 5 parallel wells.
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